AnPac Bio-Medical Science Co Profit Margin

As of the most recent data (December 2022), ANPC shows a profit margin of -841.28%. That compares with -660.08% in the prior-year period — down 27.5% year over year. That is below the Healthcare sector average of 13.76%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ANPC's profit margin is now -841.28% (was -660.08%) — a 27.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether AnPac Bio-Medical Science Co is outperforming or lagging.

The Healthcare sector average profit margin is about 13.76%. AnPac Bio-Medical Science Co is at -841.28%, which is lower that average. That is roughly 6213.8% below the sector mean. Use the comparison chart on this page to see how ANPC stacks up against individual peers as well.

That compares with -660.08% in the prior-year period — down 27.5% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare AnPac Bio-Medical Science Co with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has AnPac Bio-Medical Science Co's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -841.28%) with ownership activity and broader fundamentals.